VCP
AMPE

Verus Capital Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Verus Capital Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1K Hold
7
– – ﹤0.01% 1453
2019
Q4 		$1K Buy
+7
New +$904 ﹤0.01% 1507

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
HC
HNP Capital Rochester, New York $359M AUM 3.18% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Verus Capital Partners's AMPE Position: Q1 2020 in Review

Verus Capital Partners held its Ampio Pharmaceuticals Inc. (AMPE) position steady in Q1 2020 at 7 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1453.

Verus Capital Partners first reported a position in AMPE in Q4 2019 and has held it in 2 quarters since. 77 funds tracked by Wall St. Rank hold AMPE as of Q1 2020.

  • Verus Capital Partners held 7 shares of Ampio Pharmaceuticals Inc. worth $1K as of Q1 2020.
  • Verus Capital Partners left its Ampio Pharmaceuticals Inc. share count unchanged in Q1 2020.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1453 holding.
  • Verus Capital Partners first reported a position in Ampio Pharmaceuticals Inc. in Q4 2019 and has held it in 2 quarters since.
  • 77 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.